Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Nimrata Hunt, insider at IDEXX Laboratories
Nimrata Hunt Insider Alerts

Get notified the next time Nimrata Hunt buys or sells IDEXX Laboratories stock. Enter your email address below to get our daily insider buying and selling report.

Nimrata Hunt Insider Information

Dr. Hunt has been an Executive Vice President of IDEXX and the General Manager of Point of Care Diagnostics, and Worldwide Operations since January 2020. Prior to that, she served as a Corporate Vice President at IDEXX from November 2016 to January 2020, with a portfolio that included the company’s IDEXX VetLab, Diagnostic Imaging, and Telemedicine businesses. Dr. Hunt joined IDEXX in 2006 and served in various leadership roles in support of the company’s robust innovation pipeline, most recently leading the IDEXX VetLab organization as General Manager. In this role, she led development of market-leading veterinary diagnostic analyzers and assays for a growing and increasingly complex global market. Prior to joining IDEXX, Dr. Hunt served as Vice President at Woodard Curran, where she led the firm's litigation support practice. She holds a PhD in environmental engineering from Purdue University, an MBA from the University of Southern Maine, and is a graduate of the Stanford University Graduate School of Business’s Executive Education Program.

How do I contact Nimrata Hunt?

The corporate mailing address for Dr. Hunt and other IDEXX Laboratories executives is ONE IDEXX DRIVE, WESTBROOK ME, 04092. IDEXX Laboratories can also be reached via phone at (207) 556-0300 and via email at [email protected]

Has Nimrata Hunt been buying or selling shares of IDEXX Laboratories?

Nimrata Hunt has not been actively trading shares of IDEXX Laboratories within the last three months. Most recently, Nimrata Hunt sold 538 shares of the business's stock in a transaction on Thursday, August 5th. The shares were sold at an average price of $703.00, for a transaction totalling $378,214.00.

Who are IDEXX Laboratories' active insiders?

IDEXX Laboratories' insider roster includes Jonathan Ayers (Director), Nimrata Hunt (EVP), Daniel Junius (Director), Michael Lane (EVP), Brian Mckeon (CFO), James Polewaczyk (EVP), M. Szostak (Director), Kathy Turner (SVP), Kathy Turner (SVP), and Giovani Twigge (SVP).

Are insiders buying or selling shares of IDEXX Laboratories?

During the last year, insiders at the sold shares 24 times. They sold a total of 113,938 shares worth more than $66,392,641.61. The most recent insider tranaction occured on November, 29th when EVP James F Polewaczyk sold 4,595 shares worth more than $2,908,635.00. Insiders at IDEXX Laboratories own 2.1 % of the company.

Information on this page was last updated on 11/29/2021.

Nimrata Hunt Insider Trading History at IDEXX Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/5/2021Sell538$703.00$378,214.00View SEC Filing Icon  
11/5/2020Sell2,098$470.08$986,227.84View SEC Filing Icon  
8/14/2020Sell2,776$377.50$1,047,940.00View SEC Filing Icon  
See Full Table

Nimrata Hunt Buying and Selling Activity at IDEXX Laboratories

This chart shows Nimrata Hunt's buying and selling at IDEXX Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

IDEXX Laboratories Company Overview

IDEXX Laboratories logo
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: CAG, Water, LPD, and Other. The CAG segment develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services, which are used to manage the health status of livestock and poultry, to improve producer, and to ensure the quality and safety of milk and food. The Other operating segment combines and presents products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983 and is headquartered in Westbrook, ME.
Read More

Today's Range

Now: $586.54
Low: $575.59
High: $608.11

50 Day Range

MA: $629.13
Low: $586.54
High: $666.48

2 Week Range

Now: $586.54
Low: $447.82
High: $706.95

Volume

451,889 shs

Average Volume

337,249 shs

Market Capitalization

$49.73 billion

P/E Ratio

67.19

Dividend Yield

N/A

Beta

0.94
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!